Developing New Functional Food and Nutraceutical Products

Table of Contents

1. Growth Pattern & Emerging Opportunities in Nutraceutical and Functional Food Industries: Market Analysis 2. Market Analysis and Concept Development of Functional Foods 3. Marketing Challenges and Strategies 4. The Strategic Viewpoints of Innovation and Marketing Teams on the Development of Novel Functional Foods 5. Food Safety: Marketing Trends Intended for Consumer Awareness and Partnership 6. Intellectual Property Considerations 7. Regulatory Constraints on New Product Development and Approval Procedures in the United States 8. Formulations and Challenges: A Special Emphasis on Stability and Safety Evaluations 9. Nutraceutical Formulations and Challenges 10. Sourcing, Supply Chain and Manufacturing of Nutraceutical & Functional Foods 11. Raw Materials Analysis and Quality Control 12. Strategize the Research Investigations: Pre-Clinical and Clinical Evaluations 13. Concepts of Flavor Creation in Novel Nutraceuticals and Functional Food Formulations 14. Mind Genomics, Cognitive Economics, and the Dollar Value and the Acceptance of Sensory and Other Messaging for Bread 15. Global Market Entry Regulations for Nutraceuticals, Functional Foods, Dietary/Food/ Health Supplements 16. U.S. Regulation of Food Label Claims 17. Nutraceutical and Functional Food Regulations in the European Union 18. Health Foods and Foods with Health Claims in the Asian Subcontinent Countries of the Association of Southeast Asian Nations 19. Nutraceutical Innovation and Health Claims in China 20. Functional foods in line with young consumers: Challenges in the Marketplace in Slovenia 21. Medical Foods and US Regulations 22. Regulatory Approvals, Intellectual Property, Branding and Trademark in Nutraceuticals and Functional Foods 23. Nutrition in Wound Inflammation 24. Development of Low Cost and Eco-Friendly Feed for Various Candidate Species for the Sustainability of Commercial Aquaculture and Reduction of Aquatic Pollution 25. Global Alert: The Botanicals Resourcing 26. Strategies on Adverse Event Reporting: A Global Framework for Nutraceutical Industry 27. Genetically Modified Products and GMO Foods: A Game of Chance?

Authors

Debasis Bagchi Professor, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, USA; Chief Scientific Officer, Cepham Research Center, Piscataway, New Jersey; Adjunct Faculty, Texas Southern University, Houston, Texas, USA. Debasis Bagchi, PhD, MACN, CNS, MAIChE, received his Ph.D. in Medicinal Chemistry in 1982. He is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy, Houston, TX, and Chief Scientific Officer at Cepham Research Center, Piscataway, NJ, Adjunct Faculty in Texas Southern University, Houston, TX. He served as the Senior Vice President of Research & Development of InterHealth Nutraceuticals Inc, Benicia, CA, from 1998 until Feb 2011, and then as Director of Innovation and Clinical Affairs, of Iovate Health Sciences, Oakville, ON, until June 2013. Dr. Bagchi received the Master of American College of Nutrition Award in October 2010. He is the Past Chairman of International Society of Nutraceuticals and Functional Foods (ISNFF), Past President of American College of Nutrition, Clearwater, FL, and Past Chair of the Nutraceuticals and Functional Foods Division of Institute of Food Technologists (IFT), Chicago, IL. He is serving as a Distinguished Advisor on the Japanese Institute for Health Food Standards (JIHFS), Tokyo, Japan. Dr. Bagchi is a Member of the Study Section and Peer Review Committee of the National Institutes of Health (NIH), Bethesda, MD. He has published 321 papers in peer reviewed journals, 30 books, and 18 patents. Dr. Bagchi is also a Member of the Society of Toxicology, Member of the New York Academy of Sciences, Fellow of the Nutrition Research Academy, and Member of the TCE stakeholder Committee of the Wright Patterson Air Force Base, OH. He is also Associate Editor for the Journal of Functional Foods, Journal of the American College of Nutrition, and the Archives of Medical and Biomedical Research, and is also serving as Editorial Board Member of numerous peer reviewed journals, including Antioxidants & Redox Signaling, Cancer Letters, Toxicology Mechanisms and Methods, and The Original Internist, among others. Nair Sreejayan School of Pharmacy, University of Wyoming, Laramie, WY, USA. Dr. Sreejayan Nair is a Professor of Pharmacology and the Associate Dean for Research in the School of Pharmacy, College of Health Sciences, University of Wyoming. He also serves as the Director of the interdisciplinary Biomedical Sciences Graduate Program in the University of Wyoming. Dr. Nair earned his bachelors, masters and PhD degree in Pharmaceutical Sciences from the College of Pharmaceutical Sciences, Manipal, India. He received his post-doctoral trainings at the Department of Medicine-II, Ludwig Maximillians University, Klinikum Grosshadern, Munich, Germany, and at the Department of Physiology, University of Tennessee Health Sciences Center, Memphis, TN. His research interests are diabetes and cardiovascular disease. He has published over 75 research papers in peer-reviewed journals and presented at various national and international conferences. His research has been funded by the American Heart Association, American Diabetes Association, and the National Institutes of Health. He has co-edited three books related to diabetes and cardiovascular disease. He is a Fellow of the American College of Nutrition.